Skip to main content

Table 2 The APACHE (Acute Physiology and Chronic Health Evaluation) III diagnostic groups of the patients

From: Population-based incidence, mortality and quality of life in critically ill patients treated with renal replacement therapy: a nationwide retrospective cohort study in finnish intensive care units

 

RRT

Non-RRT

Total no. of patients*

1,685

23,208

Non-operative

1,275 (75.7%)

13,782 (59.4%)

Cardiovascular

153 (9.1%)

3,111 (13.4%)

Gastrointestinal

149 (8.8%)

1,338 (5.8%)

Hematological

22 (1.3%)

65 (0.3%)

Metabolic

102 (6.1%)

891 (3.8%)

Neurological

74 (4.4%)

2,423 (10.4%)

Renal

257 (15.3%)

159 (0.7%)

Respiratory

146 (8.7%)

2,572 (11.1%)

Sepsis

284 (16.9%)

1,110 (4.8%)

Trauma

25 (1.5%)

1,115 (4.8%)

Other

44 (2.6%)

661(2.8%)

Missing

19 (1.1%)

337 (1.5%)

Postoperative

410 (24.3%)

9,426 (40.6%)

Cardiovascular

177 (10.5%)

2,947 (12.7%)

Gastrointestinal

137 (8.1%)

2,290 (9.9%)

Gynecological

8 (0.5%)

313 (1.3%)

Neurological

29 (1.7%)

2,060 (8.9%)

Orthopedic

7 (0.4%)

391 (1.7%)

Renal

12 (0.7%)

224 (1.0%)

Respiratory

13 (0.8%)

563 (2.4%)

Trauma

11 (0.7%)

419 (1.8%)

Missing

16 (0.9%)

219 (0.9%)

  1. RRT; renal replacement therapy, non-RRT; patients without renal replacement therapy * Data on APACHE III diagnosis group were missing for one RRT patient and 10 non-RRT patients.